Pangea Wellness Inc.
PNGAF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.16 | -0.00 | 0.00 |
| FCF Yield | -147.03% | -20.66% | -18.71% | -4.45% |
| EV / EBITDA | -0.19 | -2.87 | -4.23 | -72.32 |
| Quality | ||||
| ROIC | 172.86% | 1,188.39% | -313.33% | -14.14% |
| Gross Margin | 56.59% | -11.48% | 5.87% | -98.18% |
| Cash Conversion Ratio | 0.43 | 0.59 | 0.63 | 3.06 |
| Growth | ||||
| Revenue 3-Year CAGR | -74.05% | 60.95% | 887,067.70% | 409,053.52% |
| Free Cash Flow Growth | 55.19% | -35.12% | -22.86% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.13 | 0.03 | 0.08 | 4.69 |
| Interest Coverage | 0.00 | 0.00 | -1.41 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 5.33 | 7.44 | 20.22 |
| Cash Conversion Cycle | -33,222.10 | -139.32 | 46.02 | 306.65 |